Replies to post #3244 on Marker Therapeutics Inc (MRKR)

[Bio7mm]

After the RS Tapimmune will not be a penny stock as it will be at $2 or higher if the price stays at current levels or drifts higher. Arrowhead started their run at around $2 when the capital raises started lifting their stock price higher and higher.